Panagora Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Buy |
491,314
+215,933
| +78% | +$47.9M | 0.4% | 48 |
|
|
2025
Q4 | $62.9M | Buy |
275,381
+110,087
| +67% | +$25.1M | 0.22% | 101 |
|
|
2025
Q3 | $38.3M | Buy |
165,294
+30,472
| +23% | +$6.21M | 0.15% | 135 |
|
|
2025
Q2 | $25M | Sell |
134,822
-86,877
| -39% | -$16.1M | 0.11% | 174 |
|
|
2025
Q1 | $46.5M | Sell |
221,699
-414,365
| -65% | -$80.6M | 0.23% | 104 |
|
|
2024
Q4 | $113M | Sell |
636,064
-112,188
| -15% | -$20.6M | 0.52% | 44 |
|
|
2024
Q3 | $148M | Buy |
748,252
+308,116
| +70% | +$57.5M | 0.71% | 28 |
|
|
2024
Q2 | $75.5M | Sell |
440,136
-386,883
| -47% | -$64.1M | 0.38% | 64 |
|
|
2024
Q1 | $151M | Sell |
827,019
-3,827
| -0.5% | -$660K | 0.79% | 20 |
|
|
2023
Q4 | $129M | Buy |
830,846
+171,314
| +26% | +$25M | 0.72% | 29 |
|
|
2023
Q3 | $98.3M | Sell |
659,532
-20,869
| -3% | -$3.06M | 0.61% | 39 |
|
|
2023
Q2 | $91.7M | Sell |
680,401
-45,043
| -6% | -$6.61M | 0.54% | 39 |
|
|
2023
Q1 | $116M | Buy |
725,444
+37,754
| +5% | +$5.77M | 0.73% | 23 |
|
|
2022
Q4 | $111M | Buy |
687,690
+40,421
| +6% | +$6.2M | 0.73% | 20 |
|
|
2022
Q3 | $86.9M | Buy |
647,269
+30,381
| +5% | +$4.36M | 0.6% | 28 |
|
|
2022
Q2 | $94.5M | Buy |
616,888
+99,775
| +19% | +$15.2M | 0.62% | 27 |
|
|
2022
Q1 | $83.8M | Sell |
517,113
-259,272
| -33% | -$37.7M | 0.46% | 43 |
|
|
2021
Q4 | $105M | Buy |
776,385
+20,910
| +3% | +$2.47M | 0.56% | 33 |
|
|
2021
Q3 | $81.5M | Buy |
755,475
+85,530
| +13% | +$9.77M | 0.44% | 45 |
|
|
2021
Q2 | $75.5M | Sell |
669,945
-29,480
| -4% | -$3.32M | 0.4% | 48 |
|
|
2021
Q1 | $75.7M | Buy |
699,425
+645,670
| +1,201% | +$69.1M | 0.43% | 47 |
|
|
2020
Q4 | $5.76M | Sell |
53,755
-874,910
| -94% | -$84.1M | 0.03% | 396 |
|
|
2020
Q3 | $81.3M | Sell |
928,665
-202,049
| -18% | -$19M | 0.51% | 38 |
|
|
2020
Q2 | $111M | Sell |
1,130,714
-61,461
| -5% | -$5.41M | 0.71% | 21 |
|
|
2020
Q1 | $90.8M | Sell |
1,192,175
-67,728
| -5% | -$5.77M | 0.64% | 28 |
|
|
2019
Q4 | $112M | Sell |
1,259,903
-28,313
| -2% | -$2.35M | 0.51% | 47 |
|
|
2019
Q3 | $97.5M | Sell |
1,288,216
-300,568
| -19% | -$20.6M | 0.45% | 52 |
|
|
2019
Q2 | $116M | Buy |
1,588,784
+1,337,547
| +532% | +$105M | 0.52% | 44 |
|
|
2019
Q1 | $20.2M | Sell |
251,237
-74,047
| -23% | -$6.06M | 0.09% | 226 |
|
|
2018
Q4 | $30M | Sell |
325,284
-20,832
| -6% | -$1.83M | 0.14% | 159 |
|
|
2018
Q3 | $32.7M | Sell |
346,116
-615,307
| -64% | -$58.4M | 0.12% | 172 |
|
|
2018
Q2 | $89.1M | Sell |
961,423
-378,710
| -28% | -$37M | 0.35% | 73 |
|
|
2018
Q1 | $127M | Buy |
1,340,133
+678,653
| +103% | +$74.6M | 0.5% | 45 |
|
|
2017
Q4 | $64M | Sell |
661,480
-89,043
| -12% | -$8.39M | 0.24% | 106 |
|
|
2017
Q3 | $66.7M | Sell |
750,523
-393,684
| -34% | -$30M | 0.26% | 95 |
|
|
2017
Q2 | $83M | Buy |
1,144,207
+448,180
| +64% | +$30.1M | 0.33% | 70 |
|
|
2017
Q1 | $45.4M | Sell |
696,027
-156,191
| -18% | -$9.82M | 0.19% | 127 |
|
|
2016
Q4 | $53.4M | Sell |
852,218
-36,152
| -4% | -$2.21M | 0.24% | 99 |
|
|
2016
Q3 | $56M | Buy |
888,370
+45,812
| +5% | +$2.97M | 0.27% | 86 |
|
|
2016
Q2 | $52.2M | Sell |
842,558
-104,217
| -11% | -$6.35M | 0.26% | 79 |
|
|
2016
Q1 | $54.1M | Sell |
946,775
-880,909
| -48% | -$49.1M | 0.27% | 82 |
|
|
2015
Q4 | $108M | Sell |
1,827,684
-243,165
| -12% | -$14M | 0.53% | 40 |
|
|
2015
Q3 | $113M | Sell |
2,070,849
-1,294,776
| -38% | -$84.3M | 0.59% | 34 |
|
|
2015
Q2 | $226M | Sell |
3,365,625
-11,210
| -0.3% | -$732K | 1.13% | 7 |
|
|
2015
Q1 | $198M | Buy |
3,376,835
+226,322
| +7% | +$13.7M | 1% | 8 |
|
|
2014
Q4 | $206M | Buy |
3,150,513
+169,923
| +6% | +$10.7M | 1.05% | 10 |
|
|
2014
Q3 | $172M | Sell |
2,980,590
-835,489
| -22% | -$46.4M | 0.83% | 15 |
|
|
2014
Q2 | $215M | Buy |
3,816,079
+5,816
| +0.2% | +$305K | 1.05% | 11 |
|
|
2014
Q1 | $196M | Sell |
3,810,263
-173,505
| -4% | -$8.77M | 0.92% | 14 |
|
|
2013
Q4 | $210M | Sell |
3,983,768
-1,038,858
| -21% | -$51.1M | 0.97% | 13 |
|
|
2013
Q3 | $225M | Sell |
5,022,626
-637,149
| -11% | -$28.2M | 1.1% | 11 |
|
|
2013
Q2 | $234M | Buy |
+5,659,775
| New | +$248M | 1.2% | 12 |
|
Other funds holding ABBV
VCM
VPM
Panagora Asset Management's ABBV Position: Q1 2026 in Review
Panagora Asset Management increased its AbbVie (ABBV) stake by 78% in Q1 2026, buying an estimated $47.9M and bringing the position to 491,314 shares worth $107M. The position accounts for 0.4% of the portfolio, ranked #48.
Panagora Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $234M in Q2 2013. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Panagora Asset Management held 491,314 shares of AbbVie worth $107M as of Q1 2026.
- Panagora Asset Management bought 215,933 AbbVie shares in Q1 2026, an estimated $47.9M.
- AbbVie made up 0.4% of Panagora Asset Management's portfolio in Q1 2026, its #48 holding.
- Panagora Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Panagora Asset Management's AbbVie position peaked at $234M in Q2 2013.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.